We are live on ! Find out more
TROVW

TrovaGene, Inc. Warrant
TROVW

Delisted

TROVW was delisted on the 30th of May, 2017.

Back to rankings

2 hedge funds and large institutions have $1.95M invested in TrovaGene, Inc. Warrant in 2013 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

31% less capital invested

Capital invested by funds: $2.84M → $1.95M (-$885K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$4.77K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$10.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$1.95M -$10.8K -2,300 -0.4%
TRCT
2
Tower Research Capital (TRC)
New York
$4K +$4.77K +1,015 +1,353%

TROVW Hedge Fund Activity: Q4 2013 in Review

2 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q4 2013, worth a combined $1.95M — down 31% from $2.84M a quarter earlier.

Fund positioning in TROVW was balanced in Q4 2013: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Tower Research Capital (TRC), adding an estimated $4.77K. The largest seller was Millennium Management, cutting an estimated $10.8K.

  • 2 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q4 2013, unchanged from Q3 2013.
  • Funds reported $1.95M of TrovaGene, Inc. Warrant stock for Q4 2013, down 31% quarter-over-quarter.
  • 0 funds opened new TrovaGene, Inc. Warrant positions in Q4 2013 and 0 closed out.
  • The largest TrovaGene, Inc. Warrant buyer in Q4 2013 was Tower Research Capital (TRC), an estimated $4.77K added.
  • The largest TrovaGene, Inc. Warrant seller in Q4 2013 was Millennium Management, an estimated $10.8K sold.

Based on aggregated 13F filings for Q4 2013.